Company intelligence / Profile preview

Yunnan Haopy Pharmaceutical

Ownership: Private
Development stage: Commercial

Overview

Yunnan Haopy Pharmaceutical Sales Co., Ltd. is a wholly-owned subsidiary of Yunnan Pharma, operating primarily as a pharmaceutical sales and distribution arm for the Yunnan Baiyao Group throughout Yunnan Province. It does not conduct its own research & development or maintain an independent therapeutic pipeline.

Industry: Non-Academic Healthcare

Drug pipeline

2 assets

bulleyaconitine A

Commercial

Indications: Pruritus, Pain, Joint disorders

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Yunnan Haopy Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Haopy Pharmaceutical.

Explore the full profile